Text Size
24 studies found for:    Open Studies | "Gout"

Modify this search | How to Use Search Results

Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Gout" (24 records)
Need help? See Downloading Content for Analysis
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
Condition: Recurrent or Tophacous Gout
Interventions: Other: Control;   Other: Gout Disease Management Program
2 Recruiting Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Intervention: Drug: levotofisopam
3 Recruiting Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Condition: Gout
Interventions: Drug: lesinurad;   Drug: Placebo
4 Recruiting Postmarketing Study for Determine Performance of the SIGMA HP® PARTIAL KNEE SYSTEM
Conditions: Osteoarthritis;   Post-traumatic Arthritis;   Gout;   Pseudo-gout
Intervention: Device: SIGMA HP PARTIAL KNEE
5 Recruiting Impact of Blueberries on Hyperuricemia and Gout
Conditions: Hyperuricemia;   Gout
Interventions: Dietary Supplement: Blueberry Powder;   Dietary Supplement: Placebo Powder
6 Recruiting Arthritis Research UK Gout Treatment Trial - Phase 2
Condition: Gout
Interventions: Other: Nurse intervention;   Other: Standard care
7 Recruiting The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome
Conditions: Antiphospholipid Antibodies-associated Endothelial Impairment;   Hyperurecemia;   Gout;   Metabolic Syndrome
Intervention:
8 Recruiting Observational Study of the Use of KRYSTEXXA® in Refractory Chronic Gout
Condition: Chronic Gout
Intervention: Biological: pegloticase
9 Recruiting Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
Condition: Tophaceous Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
10 Recruiting Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
11 Recruiting Combining Lesinurad With Allopurinol in Inadequate Responders
Condition: Gout
Interventions: Drug: Lesinurad;   Drug: Placebo
12 Recruiting Purine Metabolism Enzyme SNP to Uric Acid Production
Conditions: Gout;   Hyperuricemia
Intervention:
13 Recruiting Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure
Conditions: Prehypertension;   Gout;   Pulse Wave Velocity;   Hypertension;   24 Hour Blood Pressure
Intervention: Drug: Febuxostat
14 Recruiting An Open-label Extension Study With Canakinumab on the Treatment and Prevention of Gout Flares up to 3 Years
Condition: Chronic Gouty Arthritis
Intervention: Biological: canakinumab
15 Recruiting Hereditary Tubulointerstitial Nephritis
Conditions: Nephritis, Interstitial;   Chronic Renal Failure;   Gout;   Renal Cysts
Intervention: Other: Blood and urine sample collections
16 Recruiting Single and Multiple Dose Study in Japanese Subjects
Condition: Gout
Intervention: Drug: RDEA3170 and Placebo
17 Unknown † Safety and Efficacy Study of Intramuscular Uricase-PEG 20
Conditions: Gout;   Hyperuricemia
Intervention: Biological: Uricase-PEG 20
18 Recruiting Effects of Hyperuricemia Reversal on Features of the Metabolic Syndrome
Condition: Gout
Intervention: Drug: Febuxostat
19 Recruiting Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Condition: Gouty Arthritis
Interventions: Biological: Canakinumab, ACZ885;   Drug: Triamcinolone acetonide
20 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
To Top

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
† Indicates status has not been verified in more than two years